G J Hanna - JoVE Visualize

Showing results (11-20 of 14) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 14 results.

AIDS Research and Human Retroviruses|October 6, 2000

Comparative analysis of HIV type 1 genotypic resistance across antiretroviral trial treatment regimensP B Gilbert, G J Hanna, V De Gruttola, et al.

ESMO Open|May 14, 2024

First-line avelumab treatment in patients with metastatic Merkel cell carcinoma: 4-year follow-up from part B of the JAVELIN Merkel 200 studyS P D'Angelo, C Lebbé, L Mortier, et al.

Proceedings of the National Academy of Sciences of the United States of America|September 27, 2000

Antiretroviral resistance during successful therapy of HIV type 1 infectionJ Martinez-Picado, M P DePasquale, N Kartsonis, et al.

ESMO Open|March 12, 2026

Progression patterns and clinical outcomes in patients with cutaneous squamous-cell carcinoma following anti-PD-1 therapy failureK Khaddour, P Kote, M Liu, et al.

Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 14 results.

AIDS Research and Human Retroviruses|October 6, 2000

Comparative analysis of HIV type 1 genotypic resistance across antiretroviral trial treatment regimensP B Gilbert, G J Hanna, V De Gruttola, et al.

ESMO Open|May 14, 2024

First-line avelumab treatment in patients with metastatic Merkel cell carcinoma: 4-year follow-up from part B of the JAVELIN Merkel 200 studyS P D'Angelo, C Lebbé, L Mortier, et al.

Proceedings of the National Academy of Sciences of the United States of America|September 27, 2000

Antiretroviral resistance during successful therapy of HIV type 1 infectionJ Martinez-Picado, M P DePasquale, N Kartsonis, et al.

ESMO Open|March 12, 2026

Progression patterns and clinical outcomes in patients with cutaneous squamous-cell carcinoma following anti-PD-1 therapy failureK Khaddour, P Kote, M Liu, et al.

Pageof 2